Below are the most recent publications written about "Vaccines" by people in Profiles.
-
Neophytou K, Mart?nez-Ugalde I, Fenton TM, Robertson E, Strachan LJ, Jayaraman V, Harcus Y, Naar CM, Wright D, Price DRG, White R, Evans MJ, Berm?dez-Barrientos JR, Li H, Maizels RM, Aroian RV, Nisbet AJ, Abreu-Goodger C, Buck AH. An Argonaute protein traffics from nematode to mouse and is a vaccine against parasitic nematodes. EMBO Rep. 2026 01; 27(2):311-340.
-
Diray-Arce J, Chang AC, Moradipoor S, Amodio D, Carleton B, Chang WC, Crawford NW, Karoly M, Hoch A, McEnaney K, Kafil TS, Donthireddy M, Steltz SK, van Haren SD, Angelidou A, Smolen KK, Steen H, Lasky-Su J, Tran H, Liu P, Creech CB, Cutland CL, Petousis-Harris H, Nazy I, Yeung RSM, Kochhar S, Black S, Wood N, Nordenberg D, Palma P, Ovsyannikova IG, Kennedy RB, Poland GA, Ozonoff A, Chen RT, Levy O, Top KA. Longitudinal Meta-cohort study protocol using systems biology to identify vaccine safety biomarkers. Vaccine. 2025 Aug 30; 62:127504.
-
Day AM, Volkman JE. The importance of 'dread risk' for vaccine communication. J Commun Healthc. 2025 Mar; 18(1):39-46.
-
Weitzman ER, Pierce SE, Blakemore LM, Murdock A, Angelidou A, Dowling DJ, Levy O, Levy S. Need for strategic communications and stakeholder engagement to advance acceptability of an overdose preventing vaccine targeting fentanyl. Vaccine. 2024 10 24; 42(24):126082.
-
Hester MM, Carlson D, Lodge JK, Levitz SM, Specht CA. Immune evasion by Cryptococcus gattii in vaccinated mice coinfected with C. neoformans. Front Immunol. 2024; 15:1356651.
-
de Cesare M, Mwenda M, Jeffreys AE, Chirwa J, Drakeley C, Schneider K, Mambwe B, Glanz K, Ntalla C, Carrasquilla M, Portugal S, Verity RJ, Bailey JA, Ghinai I, Busby GB, Hamainza B, Hawela M, Bridges DJ, Hendry JA. Flexible and cost-effective genomic surveillance of P. falciparum malaria with targeted nanopore sequencing. Nat Commun. 2024 Feb 15; 15(1):1413.
-
Broach J, Brown O, McEachern C, Forget J, Lancette P, Soucie N, Inzerillo J, Klugman R, Tosi S, Haddad A, Manor P, Bylund R, Dellostritto G, Grecchi M, Camelo C, Shirshac J, Eshghi K, Vega N, Hampson S, Follwell K, Gonzalez R, Hicks T, McCandless V, VanStratten T, Botros M, Jalbert T, Merwin C, Schellhammer W, Pelto I, Rodriguez M, LaPriore C, Lowell M, Radigan E, Gull L, Gruszecki A, Benoit S, Dickson E, Muller M. The mobile vaccine equity enhancement program-a model program for enhancing equity in vaccine availability based at a large health care system. Front Public Health. 2023; 11:1271162.
-
Wang EY, Sarmadi M, Ying B, Jaklenec A, Langer R. Recent advances in nano- and micro-scale carrier systems for controlled delivery of vaccines. Biomaterials. 2023 12; 303:122345.
-
Bobisse S, Bianchi V, Tanyi JL, Sarivalasis A, Missiaglia E, P?tremand R, Benedetti F, Torigian DA, Genolet R, Barras D, Michel A, Mastroyannis SA, Zsiros E, Dangaj Laniti D, Tsourti Z, Stevenson BJ, Iseli C, Levine BL, Speiser DE, Gfeller D, Bassani-Sternberg M, Powell DJ, June CH, Dafni U, Kandalaft LE, Harari A, Coukos G. A phase 1 trial of adoptive transfer of vaccine-primed autologous circulating T cells in ovarian cancer. Nat Cancer. 2023 10; 4(10):1410-1417.
-
Dias Assis BR, Gomes IP, de Castro JT, Rivelli GG, de Castro NS, Gomez-Mendoza DP, Bagno FF, Hojo-Souza NS, Chaves Maia AL, Lages EB, da Fonseca FG, Ribeiro Teixeira SM, Fernandes AP, Gazzinelli RT, Castro Goulart GA. Quality attributes of CTVad1, a nanoemulsified adjuvant for phase I clinical trial of SpiN COVID-19 vaccine. Nanomedicine (Lond). 2023 08; 18(18):1175-1194.